Evidence map›Paper›PMID 41020238›Full record

ArticleFrontiers in medicine2025

Disease burden and attributable risk factors for chronic obstructive pulmonary disease in China, Japan, and South Korea: trends for 1990 to 2021 period and predictions for 2031.

Yifan Wang, Jingwen Zhu, Shaoqiang Wang, Jihong Zhou

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yifan Wang *The Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
Jingwen Zhu *The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
Shaoqiang WangSchool of Information and Control Engineering, Qingdao University of Technology, Qingdao, China.
Jihong ZhouThe Seventh Clinical College of Guangzhou University of Chinese Medicine, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a key public health concern in East Asia. China, Japan, and South Korea represent important regions in East Asia, and the three countries have various similarities in terms of culture, economic development models, and population structure. Therefore, understanding the COPD burden in these three countries is crucial for the prevention and management of COPD in East Asian. Methods: Age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), age-standardized disability-adjusted life rate (ASDR), age-period-cohort (APC) analysis, and Bayesian age-period-cohort (BAPC) analysis data of COPD in China, Japan, and South Korea were collected and determined using the GBD (Global Burden of Disease) 2021 database. Results: China had the highest COPD burden between 1990 and 2021, followed by South Korea, and Japan. The dominant risk factor related to mortality rates and DALYs was environmental/occupational risks in China, whereas behavioral risks in Japan and South Korea were more significant. BAPC predictions indicated that the ASIR, ASPR, and ASDR for COPD in China, Japan, and South Korea would exhibit a downward trend between 2021 and 2031. However, the trend of the age-standardized mortality rate (ASMR) would vary among the three countries. Conclusion: Under the influence of environmental conditions, the aging population, economic development trends, and the construction of medical security systems, China, Japan, and South Korea share commonalities as well as differences in terms of COPD burden. China's actions concerning environmental protection have been effective, although reducing smoking rates and alleviating the pollution caused by industrialization are crucial for further reducing the COPD burden in China. Owing to Japan's environmental protection policies, low smoking rates, and comprehensive social security measures, the COPD burden in Japan is relatively low compared to that in China and South Korea. Owing to the impact of environmental pollution, imperfections in the medical security system, and the influence of South Korea's handling of related issues after the economic rise of the nation, the COPD burden in South Korea has undergone significant fluctuations.

Indexed as

ageperiod-cohort analysisBayesian age-period-cohort analysischronic obstructive pulmonary diseasedisease burdenEast AsianGBD database

Identifiers

PMID41020238
PMCPMC12462641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.